SC 236
Chemical Name: 4-[5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl] benzenesulfonamide
Purity: ≥99%
Biological Activity
SC 236 is a selective COX-2 inhibitor (IC50 values are 0.005 and 17.8 μM for COX-2 and COX-1 respectively). Displays anti-inflammatory properties and potent antimetastatic activity against both experimental metastases and spontaneous metastases arising following primary tumor excision.Technical Data
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Additional Information
Background References
-
Association of Marek's Disease induced immunosuppression with activation of a novel regulatory T cells in chickens
A Gurung, N Kamble, BB Kaufer, A Pathan, S Behboudi
PLoS Pathog., 2017;13(12):e1006745. -
A single amino acid difference between cyclooxygenase-1 (COX-1) and -2 (COX-2) reverses the selectivity of COX-2 specific inhibitors.
Gierse et al.
J.Biol.Chem., 1996;271:15810 -
Antimetastatic activity of a cyclooxygenase-2 inhibitor.
Roche-Nagle et al.
Br.J.Cancer, 2004;91:359 -
Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC-58635, Celecoxib).
Penning et al.
J.Med.Chem., 1997;40:1347
Product Datasheets
FAQs
No product specific FAQs exist for this product, however you may
View all Small Molecule FAQsReviews for SC 236
There are currently no reviews for this product. Be the first to review SC 236 and earn rewards!
Have you used SC 236?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
